2235 — MicroTech Medical (Hangzhou) Share News
0.000.00%
Last trade - 00:00- HK$2.86bn
- HK$1.14bn
- CNY660.79m
Brief: Microtech Medical (Hangzhou) Receives Marketing Approval In South Korea For Linx Glucose Monitoring System
Advisory: Alert incorrectly tagged to MicroTech Medical withdrawn
Brief: Microtech Medical (Hangzhou) Says Linx Continuous Glucose Monitoring System Received Market Approval In Brazil
Brief: Microtech Medical (Hangzhou) Says Linx System Received Market Approval In India
Brief: Microtech Medical (Hangzhou) Indication For Users Of Equil Patch Insulin Pump Approved
Brief: Microtech Medical Hangzhou Says FY Loss Attributable RMB125.0
Brief: Microtech Medical Hangzhou Proposes To Elect Four Executive Directors Of Second Session Of Board
Brief: Microtech Medical Hangzhou Announces Intention To Conduct On-Market Share Repurchases
Brief: Microtech Medical Hangzhou Says Approval By CSRC For Full Circulation Of H Shares
Brief: Microtech Medical Hangzhou Says Shareholders Entered Lock-Up Undertakings For Its H Shares
Brief: Microtech Medical Hangzhou Proposes To Apply In PRC For Allotment And Issue Of A Shares
Brief: Microtech Medical Hangzhou Updates On Implementation Of Full Circulation Programme Of H Shares
Brief: Microtech Medical Hangzhou Obtained Commercial Qualification Of Ivocare Multifunctional Poct
Brief: Microtech Medical Hangzhou Says NMPA Approved Registration Of Drug For Marketing
Brief: Goldman Sachs Group Inc's Long Position In Microtech Medical Rises To 21.38% - HKEX Filing
China's diabetes treatment firm Microtech Medical climbs in Hong Kong debut